Cardiovascular Systems, Inc. (CSII)
| Previous close | 37.27 |
| Open | 37.46 |
| Bid | 38.45 x 800 |
| Ask | 38.52 x 1800 |
| Day's range | 37.33 - 38.53 |
| 52-week range | 26.00 - 55.22 |
| Volume | 136,619 |
| Avg. volume | 330,586 |
| Market cap | 1.541B |
| Beta (5Y monthly) | 1.09 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.80 |
| Earnings date | 04 Nov 2020 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 43.88 |
- Business Wire
Cardiovascular Systems, Inc. to Webcast Fiscal 2021 First-Quarter Earnings Conference Call Wednesday, November 4
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII) will host a live webcast of its fiscal 2021 first-quarter conference call on Wednesday, November 4, 2020, at 3:30 p.m. CT (4:30 p.m. ET). CSI management will discuss results for its fiscal first quarter ended September 30, 2020, and its financial outlook. CSI will issue a post-market earnings release prior to the call on November 4, 2020.
- Business Wire
Large Study Demonstrates Exceptional Safety and High Procedural Success With Cardiovascular Systems’ Diamondback 360® Coronary Orbital Atherectomy System (OAS)
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that results from a large retrospective observational study of coronary orbital atherectomy were released at TCT Connect 2020.
- Business Wire
Cardiovascular Systems Announces Presentation of Data From Large Coronary Orbital Atherectomy Study at the TCT Connect 2020 Conference
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that results from a large retrospective observational study of coronary orbital atherectomy will be released at TCT Connect 2020.
